Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

32.73
+1.765.68%
Post-market: 32.850.1200+0.37%19:59 EDT
Volume:8.25M
Turnover:265.09M
Market Cap:12.66B
PE:-3.75
High:32.84
Open:30.98
Low:30.98
Close:30.97
Loading ...

BRIEF-Moderna Says HHS Will Terminate Co's Award For Late-Stage Development Of Pre-Pandemic Influenza Vaccines

Reuters
·
29 May

Moderna: Phase 1/2 H5 Avian Flu Vaccine Study Shows Positive Interim Results

THOMSON REUTERS
·
29 May

Moderna: Will Explore Alternatives for Late-Stage Development and Manufacturing of H5 Program

THOMSON REUTERS
·
29 May

US cancels more $700 million funding for Moderna bird flu vaccine

Reuters
·
29 May

Moderna: Hhs Will Terminate Co's Award for Late-Stage Development of Pre-Pandemic Influenza Vaccines

THOMSON REUTERS
·
29 May

Kennedy, Skipping Regulatory Steps, Limits Use of Covid-19 Shots -- Barrons.com

Dow Jones
·
28 May

CDC Removes Healthy Children, Pregnant Women From COVID Vaccine Schedule

MT Newswires Live
·
27 May

US drops COVID vaccine recommendations for healthy children, pregnant women

Reuters
·
27 May

Stock Track | Moderna Soars 5.05% on FDA Application for New COVID-19 Vaccine Formula

Stock Track
·
27 May

Stock Track | Moderna Soars 5.05% on FDA Application for New COVID-19 Variant Vaccine

Stock Track
·
27 May

Moderna (MRNA) Gets a Hold from Argus Research

TIPRANKS
·
27 May

Moderna Inc. to Present at Jefferies Global Health Care Conference

Reuters
·
27 May

Barclays Keeps Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
27 May

Weekly Winners|GE Vernova And Dollar General Soared 8%; Intuit Jumps 7%; Moderna Surged 5.6%

Tiger Newspress
·
25 May

BRIEF-Moderna Files FDA Application For The Lp.8.1 Targeting Covid-19 Vaccine

Reuters
·
24 May

Moderna Files Application With FDA for COVID-19 Vaccine Review

MT Newswires Live
·
24 May

Moderna files application for updated COVID vaccine

Reuters
·
24 May

Moderna files FDA application for LP.8.1 targeting COVID-19 vaccine

TIPRANKS
·
24 May

Moderna Files FDA Application for the Lp.8.1 Targeting Covid-19 Vaccine

THOMSON REUTERS
·
24 May

Moderna: Submission Based on Guidance From U.S. FDA, Which Advised That Covid-19 Vaccines Should Be Updated to a Monovalent Jn.1 Lineage - Website

THOMSON REUTERS
·
24 May